Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma
Daxa Patel
◽
Paul Foreman
◽
Burt Nabors
◽
Kristen Riley
◽
Yancey Gillespie
◽
...
2016 ◽
Vol 27
(2)
◽
pp. 69-78
◽
Daxa M. Patel
◽
Paul M. Foreman
◽
L. Burt Nabors
◽
Kristen O. Riley
◽
G. Yancey Gillespie
◽
...
M. R. Chambers
◽
R. Timothy Bentley
◽
David K. Crossman
◽
Jeremy B. Foote
◽
Jey W. Koehler
◽
...
2014 ◽
Vol 25
(3)
◽
pp. S45
S. Ganguli
◽
R. Oklu
◽
J.W. Clark
◽
E.L. Kwak
◽
S.P. Kalva
◽
...
UM Lauer
◽
M Zimmermann
◽
U Koppenhöfer
◽
M Bitzer
◽
NP Malek
◽
...
Steve Plaxe
◽
Kristy Ward
2021 ◽
Vol 32
(1)
◽
pp. 120-121
S. Hiltbrunner
◽
C. Britschgi
◽
P. Schuberth
◽
L. Bankel
◽
T.D.L. Nguyen-Kim
◽
...
Close
Export Citation Format
Close
Share Document
Close